$UXIN

Dai Kun purchased $21K of UXIN (indirect holdings)

Dai Kun (Chief Executive Officer) purchased 18,827 indirectly-held shares of Uxin Ltd (UXIN) at an average of $1.14 ($1.13–$1.15) across 2 trades over 2026-10-09 to 2026-10-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Dai Kun
Published Oct 13, 2026, 12:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 12:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$UXIN
Bullish
medium confidence
Mentioned
$UXIN
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$UXINBullishLow
01

Why it matters

This is primarily a sentiment and positioning signal. Because the disclosed buy value is small, it is unlikely to change valuation materially without corroborating company-specific catalysts.

02

Market read

Traders may note the insider buying as a mild positive, but the transaction size and 10b5-1 context suggest limited trading impact absent other news.

03

What to watch

Indirect holdings and 10b5-1 structure reduce interpretability; traders may discount the signal versus other catalysts like earnings, guidance, or financing news.

Relevance 2/10Novelty 2/10Timing: filed 2026-10-13, covering buys from 2026-10-09 to 2026-10-12

Background

The article summarizes an SEC Form 4 insider transaction by Uxin Ltd CEO Dai Kun, including that the trades were under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$UXINBullishMedium confidence
Context

CEO Dai Kun bought 18,827 shares of Uxin Ltd in open-market trades totaling about $21.4K, disclosed via SEC Form 4.

Expected impact

Likely modest upward bias in near-term sentiment, with limited follow-through given the small transaction value.

Evidence & confidence

The filing is a primary SEC Form 4 disclosure, but the transaction value (~$21K) is small relative to typical market-moving thresholds, so impact is more signaling than fundamental.

Market effects

No clear sector read-through from a small, single-insider purchase.

None indicated.

None indicated.

Counterpoint

The purchase is under a pre-arranged 10b5-1 plan, so it may reflect scheduled liquidity/compensation mechanics rather than a new bullish view.

Key entities

  • Uxin Ltd

    Subject of the Form 4 insider transaction disclosure.

  • Dai Kun

    CEO and director who purchased shares via open-market trades under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$UXINMedAI 8/10

Uxin (UXIN) Q2 2026 Earnings Call Transcript

Uxin (UXIN) reported Q2 2026 revenue of RMB 1.51B, up 75% YoY, with retail volume up 89% and wholesale volume up 88%. Gross margin turned negative at -0.7% due to inventory adjustments. Q3 guidance: 20,500-21,000 retail units, RMB 1.16B-1.19B revenue, and >6% gross margin. CEO plans $5M share purchase. Industry consolidation expected, with 50,000-60,000 dealerships forecast to exit by year-end.

$UXINMed

Uxin Q2 Loss Widens; Shares Up

Uxin Limited reported a wider net loss of RMB 183.33 million ($27.02 million) in Q2 2026, up from RMB 73.80 million a year ago, with total revenues increasing to RMB 1.151 billion ($169.66 million). The company forecasted Q3 revenue of RMB 1.16-1.19 billion and a gross profit margin above 6.0%. Shares rose 13.30% to $1.2350 on Nasdaq.

$UXINMed

Uxin Ltd (UXIN): Financial results for Q2 2026

Uxin Ltd (UXIN) furnished an SEC Form 6-K — earnings release. Exhibit 99.1 Uxin Reports Unaudited Financial Results for the Quarter Ended June 30, 2026 BEIJING, September 24, 2026 – Uxin Limited (“Uxin” or the “Company”) (Nasdaq: UXIN), China’s leading used car retailer, today announced its unaudited financial results for the quarter ended

$UXINMed

Why is Uxin stock surging today?

Uxin (UXIN) stock rose 6.42% in pre-market trading after reporting Q2 2026 revenue of RMB1,151.2 million, up 74.9% YoY. The company projected Q3 revenue of RMB1,160-1,190 million and a gross profit margin above 6.0%, reversing a prior -0.7% margin. Management attributed margin weakness to temporary market conditions. The rally occurred despite broader market declines, highlighting company-specific optimism.

$UXINMed

Uxin Q1 Earnings Call Highlights

Uxin (NASDAQ: UXIN) reported Q1 adjusted EBITDA loss of CNY 34.3 million, widening sequentially from CNY 27.2 million, which management attributed to Chinese New Year seasonality and higher ramp-up and staffing costs. Management cited auto-market weakness: first five months’ new vehicle sales down 20% YoY and April-May ICE sales down over 35% YoY, with used ICE prices falling 10%-15% in 1-2 months. Uxin said gross margin may face more pressure in Q2, but expects improvement in Q3 if ICE prices s